If you received a sample of Taytulla birth control pills from your doctor in recent months, make sure: The manufacturer has misplaced the placebo tablets
Allergan, the manufacturer of Taytulla, announced this on Tuesday Www.celesio.com/ag/?redirect=true&n…id=4&nx=1665 The company commissioned a nationwide recall of a pill with a total of almost 170,000 packages after being alerted by a doctor to a packaging error. Englisch: www.celesio.com/ag/?redirect=true&n…13-100&lg=en.
In the packs concerned, the first four pills in the pack – and not the last four – were inactive, potentially risking pregnancy for women. According to a press release, the packaging error meant that the first four days in the pack contained the maroon placebo capsules. Typically, the packages contain pink capsules containing oral contraceptive hormones for 24 days followed by the maroon placebo capsules.
The manufacturer fears that the users of the contraceptive are the reverse Not notice sequence and thereby increase the possibility of unintentional pregnancy.
The sample packs have been in circulation nationwide since August. Affected are Lot # 5620706 with an expiration date May 2019. Allergan voluntarily recalls all units in the batch.
Allergan said that it informed customers about the recall Brief informs and encourages patients to contact their doctors with questions. Company shares fell close to 2% on Tuesday after the news of the recall.